SecSonar.com

Zoetis Inc. (ZTS)

Zoetis Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Zoetis Inc. (ZTS) is a Drug Manufacturers - General company based in US with a market capitalization of $32.6B. Revenue grew 2.3% year-over-year and the company generated $2.3B in free cash flow. This page tracks ZTS's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 13.8K employees · IPO Feb 1, 2013

Valuation

Valuation & price

$74.22 · as of May 17, 2026 · -53.3% vs 52w high

12.3

P/E ratio

Latest-FY diluted EPS

9.79

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$158$117$74.80Jul 25Dec 25Jul 26Jul 7, 25$157.05Jul 9, 25$158.27Jul 11, 25$154.96Jul 15, 25$152.86Jul 17, 25$150.03Jul 21, 25$147.37Jul 23, 25$153.45Jul 25, 25$152.12Jul 29, 25$151.01Jul 31, 25$145.79Aug 4, 25$151.81Aug 6, 25$146.50Aug 11, 25$149.02Aug 13, 25$152.44Aug 15, 25$154.11Aug 19, 25$155.67Aug 21, 25$155.61Aug 25, 25$155.19Aug 27, 25$155.37Aug 29, 25$156.40Sep 3, 25$152.43Sep 5, 25$153.32Sep 9, 25$149.79Sep 11, 25$150.61Sep 16, 25$147.46Sep 18, 25$147.10Sep 22, 25$144.65Sep 24, 25$141.67Sep 26, 25$143.50Sep 30, 25$146.32Oct 2, 25$146.49Oct 6, 25$145.36Oct 8, 25$143.49Oct 10, 25$141.11Oct 14, 25$143.46Oct 16, 25$143.26Oct 21, 25$146.09Oct 23, 25$146.39Oct 27, 25$147.53Oct 29, 25$143.94Oct 31, 25$144.09Nov 4, 25$124.46Nov 6, 25$119.56Nov 10, 25$119.79Nov 12, 25$121.25Nov 14, 25$120.82Nov 18, 25$118.14Nov 20, 25$115.89Nov 25, 25$127.89Nov 28, 25$128.18Dec 2, 25$124.44Dec 4, 25$120.41Dec 8, 25$118.16Dec 10, 25$118.07Dec 12, 25$118.66Dec 16, 25$123.23Dec 18, 25$122.76Dec 22, 25$123.78Dec 24, 25$125.49Dec 29, 25$125.98Jan 2, 26$125.92Jan 6, 26$129.35Jan 8, 26$126.85Jan 12, 26$125.32Jan 14, 26$125.84Jan 16, 26$124.65Jan 21, 26$125.08Jan 23, 26$124.05Jan 27, 26$124.96Jan 29, 26$121.72Feb 2, 26$124.94Feb 4, 26$126.70Feb 9, 26$127.30Feb 11, 26$128.67Feb 13, 26$126.65Feb 18, 26$129.13Feb 20, 26$128.78Feb 24, 26$128.66Feb 26, 26$129.76Mar 2, 26$128.96Mar 4, 26$125.96Mar 6, 26$121.43Mar 10, 26$120.49Mar 12, 26$115.48Mar 17, 26$121.68Mar 19, 26$115.99Mar 23, 26$115.23Mar 25, 26$116.71Mar 27, 26$113.35Mar 31, 26$118.21Apr 2, 26$117.94Apr 7, 26$116.80Apr 9, 26$119.99Apr 13, 26$120.08Apr 15, 26$120.76Apr 17, 26$122.38Apr 22, 26$117.52Apr 24, 26$116.87Apr 28, 26$116.65Apr 30, 26$114.97May 4, 26$112.68May 6, 26$111.22May 8, 26$82.83May 12, 26$76.94May 14, 26$75.48May 18, 26$77.72May 20, 26$79.71May 22, 26$81.32May 28, 26$78.27Jun 1, 26$77.56Jun 3, 26$77.59Jun 5, 26$79.44Jun 9, 26$82.20Jun 11, 26$81.40Jun 15, 26$79.95Jun 17, 26$77.26Jun 22, 26$75.89Jun 24, 26$78.17Jun 26, 26$76.09Jul 2, 26$74.80
$71.8652-week range$158.80
Loading valuation history…

Fundamentals

Key fundamentals

$32.6B

Market cap

2.3%

Revenue growth (YoY)

70.5%

Gross margin

$2.3B

Free cash flow (USD)

$7.2B

Net debt

-2.4%

Share dilution

3/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$4.9BFY 2017$5.3BFY 2018$5.8BFY 2019$6.3BFY 2020$6.7BFY 2021$7.8BFY 2022$8.1BFY 2023$8.5BFY 2024$9.3BFY 2025$9.5B
$4.9B$9.5B

Free cash flow by year

2016 → 2025

FY 2016$497.0MFY 2017$1.1BFY 2018$1.5BFY 2019$1.3BFY 2020$1.7BFY 2021$1.7BFY 2022$1.3BFY 2023$1.6BFY 2024$2.3BFY 2025$2.3B
$497M$2.3B

Gross margin by year

2021 → 2025

FY 202168.3%FY 202267.8%FY 202368.3%FY 202469.1%FY 202570.5%
68.3%70.5%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

3

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 7, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventDirector Retirement and Annual MeetingMay 22, 2026Filing
  • 8-K eventDividend DeclaredMay 20, 2026Filing
  • Insider buyInsider Buy $152KBisaro Paul · Director · $151.8KMay 13, 2026Filing
  • Insider buyInsider Buy $501KDAMELIO FRANK A · Director · $501.3KMay 13, 2026Filing
  • Insider buyInsider Buy $233KMCCALLISTER MICHAEL B · Director · $233.3KMay 12, 2026Filing
  • 8-K eventEarnings ReleaseMay 7, 2026Filing
  • Quarterly report10-Q FiledMay 7, 2026Filing

Questions

Frequently asked questions

What is Zoetis Inc.'s market cap?

Zoetis Inc. (ZTS) has a market capitalization of $32.6B.

What is ZTS's P/E ratio?

ZTS trades at a price-to-earnings ratio of 12.3, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is ZTS's price-to-book (P/B) ratio?

ZTS trades at 9.79 times book value per share.

Are insiders buying ZTS stock?

Yes — SEC Form 4 filings show 3 open-market insider buys and 0 sells at Zoetis Inc. in the last 90 days.

Same arena

Related companies in Drug Manufacturers - General

BIIB

Biogen Inc.

$29.2B

GRFS

Grifols, S.A.

$6.7B

OGN

Organon & Co.

$3.5B

SCLX

Scilex Holding Company

$79M

SRXH

SRx Health Solutions Inc.

$3.9M

GSK

GSK plc

$101.9B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.